SUMOylated hnRNPM suppresses PFKFB3 phosphorylation to regulate glycolysis and tumorigenesis

Ya-Xian Zhong1, Huan-Bin Zhao2, Meng-Han Lian3

  • 1Institute of Aging & Tissue Regeneration, Stress and Cancer Research Unit of Chinese Academy of Medical Sciences (No. 2019RU043), State Key Laboratory of Systems Medicine for Cancer, Ren-Ji Hospital, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, 200127, China; Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, SJTU-SM, Shanghai, 200025, China.

Cancer Letters
|February 21, 2025
PubMed

Insights

SUMOylation of heterogeneous nuclear ribonucleoprotein M (hnRNPM) regulates colorectal cancer by inhibiting glycolysis and lactate production. This novel mechanism impacts tumor growth and offers new therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Heterogeneous nuclear ribonucleoprotein M (hnRNPM) is a splicing factor involved in cancer, but its precise mechanisms are unclear.
  • Previous research focused on hnRNPM's RNA-binding and splicing roles.

Purpose of the Study:

  • To investigate the non-splicing roles of hnRNPM in colorectal cancer.
  • To identify post-translational modifications of hnRNPM in colorectal cancer cells.

Main Methods:

  • Global SUMOylated proteomic screening in colorectal cancer cells.
  • Interaction studies between hnRNPM, SENP1, and PFKFB3.
  • In vivo tumorigenesis assays in mice.
  • Analysis of patient samples for hnRNPM SUMOylation and related protein levels.

Main Results:

  • hnRNPM is SUMOylated at lysine 17, and SENP1 mediates its de-SUMOylation.
  • hnRNPM SUMOylation inhibits glycolysis by interacting with PFKFB3, affecting its localization and phosphorylation, thereby suppressing lactate production.
  • SUMO-deficient hnRNPM promotes colorectal cancer cell proliferation and tumorigenesis in mice.
  • A negative correlation exists between hnRNPM SUMOylation and SENP1 expression or phosphorylated PFKFB3 levels in colorectal cancer patient samples.

Conclusions:

  • hnRNPM SUMOylation plays a critical role in regulating colorectal cancer cell metabolism and growth independent of its splicing functions.
  • Modulating hnRNPM SUMOylation presents a potential therapeutic strategy for colorectal cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K